Resultados de la búsqueda 731-740 of 17178 for treatment resistant depression
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study to ...
Currently, only a few international institutions use CIRT to treat pelvic bone sarcomas. ... The purpose of phase 2a is to establish proof-of ... treatment. This ...
Cannabis use and the course and outcome of major depressive disorder: A population based longitudinal study. ... Journal of Substance Abuse Treatment. 2017;81:53 ...
... therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the ...
New approach to Treating Drug-Resistant Epilepsy. 48 Replies Tue, Apr 07 ... Mayo Clinic researchers lead transformative shift toward neurorestorative treatment ...
The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...
AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL ... Rochester, Minn. This is a Phase 2 global, multi-center, open-label study to ...
... treatment. Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation ... AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL.
The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?